Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science